Heterozygous Nf2+/−-mutant mice develop a spectrum of unusually highly metastatic tumours, mainly osteosarcomas, fibrosarcomas, and liver carcinomas, that exhibit loss of the wild-type allele. Here, NF2 is linked to neoplasm.